• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替格瑞洛在三维胶原支架内的成骨细胞 - 巨噬细胞共培养体系中增强碱性磷酸酶(ALP)活性并上调核因子κB受体活化因子配体(RANKL)表达。

Tideglusib enhances ALP activity and upregulates RANKL expression in Osteoblast-macrophage Co-cultures within a 3D collagen scaffold.

作者信息

Toledano Raquel, Osorio María T, Osorio Raquel, Toledano Manuel, Jacho Diego, Yildirim-Ayan Eda

机构信息

Dental School, University of Granada, Colegio Máximo de Cartuja, Granada, Spain.

Bioengineering Department, University of Toledo, Toledo, Ohio, USA.

出版信息

J Dent. 2025 Feb;153:105509. doi: 10.1016/j.jdent.2024.105509. Epub 2024 Dec 5.

DOI:10.1016/j.jdent.2024.105509
PMID:39645182
Abstract

OBJECTIVES

Tideglusib (Tx) is known for its osteogenic potential, yet its effects on the interplay between osteoblasts and M1 macrophages remain underexplored. This in vitro study aimed to isolate and evaluate both the individual and combined roles of M1 macrophages and osteoblasts in macrophage differentiation and osteoblast function, specifically focusing on how these interactions influence protein expression of osteogenesis and osteoclastogenesis in the presence or absence of Tx.

METHODS

Osteoblast and macrophage cells were co-cultured in direct contact for 24 and 48 h, with or without the presence of Tx. ALP activity, the expression of inflammatory-related genes using RT-qPCR, and histological analyses were performed.

RESULTS

Co-culturing osteoblasts and M1 macrophages with Tx increased alkaline phosphatase production, indicative of enhanced osteoblast activity. Histological assessments revealed that Tx treatment contributed to the stability and maintenance of cell morphology within the scaffold, suggesting a supportive environment for cell viability and function. Tx significantly reduced the expression of pro-inflammatory markers, such as TNF-α and IL-1β, in the co-culture at both 24 and 48 h Tx also effectively inhibited osteoclastogenic differentiation in macrophages, thereby diminishing their pro-inflammatory phenotype.

CONCLUSIONS

Tx increased ALP activity and produced a significant up-regulation of RANKL expression, indicating enhanced osteoblast differentiation and osteoclast activation. Tx mitigates macrophage-driven inflammation.

CLINICAL SIGNIFICANCE

Tx may enhance bone regeneration by modulating inflammatory responses and preserving cell integrity.

摘要

目的

替格列净(Tx)以其成骨潜能而闻名,但其对成骨细胞与M1巨噬细胞之间相互作用的影响仍未得到充分研究。本体外研究旨在分离并评估M1巨噬细胞和成骨细胞在巨噬细胞分化和成骨细胞功能中的单独作用及联合作用,特别关注在有或没有Tx的情况下这些相互作用如何影响成骨和破骨细胞生成的蛋白质表达。

方法

将成骨细胞和巨噬细胞直接接触共培养24小时和48小时,有或没有Tx存在。进行碱性磷酸酶活性检测、使用RT-qPCR检测炎症相关基因的表达以及组织学分析。

结果

将成骨细胞和M1巨噬细胞与Tx共培养可增加碱性磷酸酶的产生,表明成骨细胞活性增强。组织学评估显示,Tx处理有助于维持支架内细胞形态的稳定性,表明为细胞活力和功能提供了支持性环境。Tx在24小时和48小时均显著降低了共培养物中促炎标志物如TNF-α和IL-1β的表达。Tx还有效抑制了巨噬细胞中的破骨细胞分化,从而减轻了它们的促炎表型。

结论

Tx增加了碱性磷酸酶活性并显著上调了RANKL表达,表明成骨细胞分化和破骨细胞活化增强。Tx减轻了巨噬细胞驱动的炎症。

临床意义

Tx可能通过调节炎症反应和维持细胞完整性来促进骨再生。

相似文献

1
Tideglusib enhances ALP activity and upregulates RANKL expression in Osteoblast-macrophage Co-cultures within a 3D collagen scaffold.替格瑞洛在三维胶原支架内的成骨细胞 - 巨噬细胞共培养体系中增强碱性磷酸酶(ALP)活性并上调核因子κB受体活化因子配体(RANKL)表达。
J Dent. 2025 Feb;153:105509. doi: 10.1016/j.jdent.2024.105509. Epub 2024 Dec 5.
2
Deciphering the Cell-Specific Effect of Osteoblast-Macrophage Crosstalk in Periodontitis.解析破骨细胞-巨噬细胞相互作用在牙周炎中的细胞特异性效应。
Tissue Eng Part A. 2023 Nov;29(21-22):579-593. doi: 10.1089/ten.TEA.2023.0104. Epub 2023 Oct 6.
3
The Effect of Osteoblast Isolation Methods from Adult Rats on Osteoclastogenesis in Co-Cultures.成年大鼠成骨细胞分离方法对共培养体系破骨细胞生成的影响。
Int J Mol Sci. 2022 Jul 17;23(14):7875. doi: 10.3390/ijms23147875.
4
Inflammatory factors in the circulation of patients with active rheumatoid arthritis stimulate osteoclastogenesis via endogenous cytokine production by osteoblasts.活动期类风湿关节炎患者血液循环中的炎性因子通过成骨细胞产生内源性细胞因子刺激破骨细胞生成。
Osteoporos Int. 2014 Oct;25(10):2453-63. doi: 10.1007/s00198-014-2779-1. Epub 2014 Jul 16.
5
Chitosan-Collagen 3D Matrix Mimics Trabecular Bone and Regulates RANKL-Mediated Paracrine Cues of Differentiated Osteoblast and Mesenchymal Stem Cells for Bone Marrow Macrophage-Derived Osteoclastogenesis.壳聚糖-胶原 3D 基质模拟小梁骨,并调节 RANKL 介导的分化成骨细胞和间充质干细胞的旁分泌信号,用于骨髓巨噬细胞来源的破骨细胞生成。
Biomolecules. 2019 May 5;9(5):173. doi: 10.3390/biom9050173.
6
DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.DOK3 通过负向调节破骨细胞生成和正向调节成骨细胞生成来调节骨重塑。
J Bone Miner Res. 2017 Nov;32(11):2207-2218. doi: 10.1002/jbmr.3205. Epub 2017 Aug 2.
7
Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.槟榔碱可抑制体外 RANKL 诱导的破骨细胞分化,并减轻体内 LPS 诱导的骨丢失。
Phytomedicine. 2020 Apr;69:153195. doi: 10.1016/j.phymed.2020.153195. Epub 2020 Feb 22.
8
Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.香叶基香叶酸对骨骼的影响:诱导成骨细胞分化并抑制破骨细胞形成。
J Bone Miner Res. 2002 Jan;17(1):91-100. doi: 10.1359/jbmr.2002.17.1.91.
9
The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.辣椒素受体 TRPV1 离子通道拮抗剂 Capsazepine 可抑制体外破骨细胞和成骨细胞分化,并抑制体内卵巢切除诱导的骨丢失。
Bone. 2010 Apr;46(4):1089-99. doi: 10.1016/j.bone.2010.01.368. Epub 2010 Jan 22.
10
A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro.一种Jak1/2抑制剂,巴瑞替尼,在体外通过抑制成骨细胞中RANKL的表达来抑制破骨细胞生成。
PLoS One. 2017 Jul 14;12(7):e0181126. doi: 10.1371/journal.pone.0181126. eCollection 2017.

引用本文的文献

1
Injectable GSK3 inhibitor (Tideglusib) hydrogel versus enhanced β-tricalcium phosphate in tibial bone healing (in vitro and in vivo study).可注射的糖原合成酶激酶3抑制剂( Tideglusib)水凝胶与增强型β-磷酸三钙用于胫骨骨愈合的比较(体外和体内研究)
Odontology. 2025 Sep 21. doi: 10.1007/s10266-025-01203-4.